Unknown NA INTERVENTIONAL 2-arm NCT05655117

Application of Artificial Intelligence in Early Detection of Eye Complications in Diabetics (AI)

Application of Artificial Intelligence in Early Detection of Eye Complications in Diabetics: A Randomized Clustered Trial in Hail, Saudi Arabia

Sponsor: Health Holding Company, Hail Health Cluster

Conditions Artificial Intelegence Diabetic Retinopathy Associated With Type 2 Diabetes Mellitus Macular Edema Due to Type 2 Diabetes Mellitus

Interventions AI based eye screening

Updated 5 times since 2023 Last updated: Dec 27, 2022 Started: Jan 31, 2023 Primary completion: Jun 30, 2023 Completion: Jul 31, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Artificial Intelegence and Diabetic Retinopathy Associated With Type 2 Diabetes Mellitus and is currently ongoing. Health Holding Company, Hail Health Cluster leads this study, which shows 5 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Jan 2025 — Present [monthly]

Unknown NA

Status: Not Yet Recruiting → Unknown
Sep 2024 — Jan 2025 [monthly]

Not Yet Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting NA
Feb 2023 — Jul 2024 [monthly]

Not Yet Recruiting NA
Jan 2023 — Feb 2023 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Health Holding Company, Hail Health Cluster
The New Model of Care, Hail Health Cluster

Data source: The New Model of Care, Hail Health Cluster

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.